Abstract We report a rare case of a woman with bilateral papillary cystadenomata of the broad ligament with von Hippel-Lindau disease (VHL) (other manifestations: capil-
Introduction
Von Hippel-Lindau disease (VHL) was Wrst described in 1926 as an inherited disease, characterized by tumors of the retina, brain, kidney, adrenal gland, and pancreas. Recently the VHL gene was identiWed as a tumor suppressor gene on the short arm of chromosome 3 (3p25-26). VHL disease is an autosomal dominantly inherited multisystemic tumor syndrome due to a gene mutation with an incidence of one in 36,000 live births [1] . In 20% of cases de novo mutations occur [2] . The mutations cause a situation analogous to hypoxia with an increase in various growth and angiogenic factors [3] .
AVected individuals are at high risk for developing various benign and malignant tumors. Lesions in VHL disease tend to be multiple and bilateral in paired organs (Table 1 ) [1, [4] [5] [6] . Though rarely described in the literature (n = 4), a benign adnexal papillary tumor of probable mesonephric origin (APMO) is highly signiWcantly associated with VHL disease. The WHO classiWcation diVerentiates between two main clinical types, based on the risk for developing a pheochromocytoma and/or renal cell carcinoma and is related to the type of mutation (Table 2) [1, 7] .
Most tumors develop at younger age, i.e. between 20 and 40 years. The penetrance of the disease is about 96% by the age of 60 years with renal cell cancer in 69%, retinal tumor in 70% and cerebellar hemangioblastoma in 85% [1, 6] .
Metastases determine the prognosis and can be found in patients with renal cell carcinoma, rarely in pheochromocytomas or islet cell tumors. Intracerebral hemorrhages due to bleeding from carcinomas or hemangioblastomas of the brain are the main cause of death [4] .
Improved surveillance, earlier diagnosis of the lesions with modern imaging (MRI), improvements in treatment and increased knowledge of this disease have resulted in an improved prognosis and reduced rates of complications. An interdisciplinary team is beneWcial for optimal assessment, treatment, and follow-up. It is also recommended that the family of the index patient is examined, because individuals with a predisposition for an inherited tumor syndrome, such as VHL disease, beneWt from early screening at around 11 years of age, ophthalmologic examination, catecholamine testing, and magnetic resonance imaging [4] .
Case report
A woman aged 23, nulligravida, underwent a gynecological examination at our institution, because of lower abdominal pain of unclear etiology. Ultrasonographic examination revealed a partly solid, partly cystic mass of 3.5 cm diameter in the right adnexal region (Fig. 1) . Ca-125 was within normal limits (15.9 U/ml). Laparoscopy was performed and a cystic tumor was found in the right mesosalpinx (Fig. 2) and removed completely. In the left mesosalpinx a smaller (8 mm diameter) cystic tumor was detected and subsequently removed. On both sides ovaries and fallopian tubes were unaVected and could be preserved.
Histological examination revealed bilateral clear cell papillary cystadenomas of the mesosalpinx. The tumors were composed of tightly packed papillae with loose or dense Wbrous cores, covered by a monolayered epithelium (Fig. 3) . These Wndings prompted genetic testing on the adnexal papillary tumor of probable mesonephric origin (APMO) and showed a point mutation P86L on the exon 1 of the VHL gene. The patient has been counseled accordingly.
Five years before, the patient had undergone a laminectomy of thoracic vertebrae 2 and 3 for symptomatic capillary hemangioma with insertion of syringoperitoneal drainage (Fig. 4) . The size of the hemangioblastoma of the thoracic vertebral column at that time was 3 £ 1.5 cm. During follow-up, MRI now shows two additional similar lesions at the cervical vertebral body IV (1 £ 1 cm) and the sacral body which until now have been treated conservatively and examined every 6-12 months (picture not shown).
Comment
Papillary cystadenomas of the mesosalpinx are rare benign lesions. Bilaterality can be a diagnostic hint of VHL disease [1] . Surgery is necessary if symptoms occur. The APMO is histologically identical to the papillary cystadenoma of the epididymis in males, where it is usually diagnosed easier [8, 9] . With regard to long-term consequences proper follow-up concerning renal cell carcinoma is mandatory, because the risk of metastatic disease increases with tumor size [4] . Vice versa proper surveillance of the gonadal region in VHL patients is necessary, since metastasis of renal cell carcinomas to the adnexae and epididymes are described. These metastases might even develop within existing VHL lesions, such as in hemangioblastoma of the brain or in cystadenomas of the epididymis, the adrenal gland, and in the gall bladder [7] .
The histological similarity between papillary cystadenoma and renal cell carcinoma can be explained by the similar phylogenetic origin of renal tubules, ductules eVerentes, and mesonephric remnants [10] . Thus papillary cystadenomas can be found intra-and extraperitoneally in remnant parts of the mesonephric duct including the broad ligament, the mesosalpinx, along the lateral wall of the uterus and in the wall of the vagina [11, 12] . There are reports on VHL tumors of both Mullerian and WolYan origin containing numerous glands (characterized by tall columnar cells) [9, 13] . Interestingly, these lesions might be associated with a histological identical papillary middle ear/temporal bone tumor [11] . Our patient presented with VHL manifestations in the adnexae and in the spinal column. We report this case because only the gynecological Wndings prompted the deWnitive genetic tests. Our case report intends to make gynecologists aware that APMO could be a Wrst manifestation of VHL disease. Since early diagnosis is relevant for long-term prognosis of the patient and its family, the gynecologist should trigger genetic tests and imaging studies to prove or rule out VHL disease.
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